Pseudouridine Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-02-19　·　168 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 39.9 Mn
2033 年預估規模: USD 54.7 Mn
年複合成長率 CAGR: 4.6%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-02-19頁數 168報告編號 CMI9354

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Pseudouridine Market, By Product Type (Chemistry) (Pseudouridine and N1-methylpseudouridine), By Purity (Research Grade (RUO), GMP / Clinical Grade, and Commercial / API Grade), By Form (Powder (lyophilized / crystalline) and Solution (aqueous / buffered)), By Application (mRNA Therapeutics (human), mRNA Vaccines (human), mRNA Veterinary (vaccines / therapeutics), Oligonucleotide / RNA Tools (controls, standards, probes), Cell & Gene Therapy Research (RNA engineering workflows), and Diagnostics & Assays (RNA-based kits, calibration materials)), By End User (Pharma & Biopharma Companies, CDMOs / CMOs (RNA synthesis, LNP formulation, fill-finish), CROs (preclinical/clinical support labs), Academic & Research Institutes, Government / Public Health Labs, and Diagnostic Companies), By Pack Size (Micro (100 mg), (Small (100 mg1 g), Medium (125 g), and Bulk (25 g))), By Distribution Channel (Online and Offline), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

According to Coherent Market Insights, the global pseudouridine market is estimated to be valued at USD 39.9 Mn in 2026 and is expected to reach USD 54.7 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.6% from 2026 to 2033. The global pseudouridine market represents a rapidly evolving segment within the pharmaceutical and biotechnology industries, driven by the compound's critical role in RNA modifications and therapeutic applications. Pseudouridine, often referred to as the fifth nucleoside, is a naturally occurring modified nucleoside that plays essential functions in cellular processes, particularly in ribosomal RNA and transfer RNA stability and function. This isomer of uridine has gained significant attention in recent years due to its pivotal role in mRNA vaccine technology, particularly following the COVID-19 pandemic, where pseudouridine modifications enabled the development of highly effective mRNA vaccines. Beyond vaccine applications, pseudouridine demonstrates promising potential in gene therapy, cancer treatment, and various therapeutic interventions where RNA stability and immune evasion are crucial. The market encompasses various forms including synthetic pseudouridine, modified pseudouridine derivatives, and pseudouridine-containing oligonucleotides used across research institutions, pharmaceutical companies, and biotechnology firms. As the understanding of RNA biology advances and the demand for innovative therapeutic modalities increases, the pseudouridine market is positioned for substantial growth, supported by ongoing research initiatives, regulatory approvals, and expanding applications in personalized medicine and advanced therapeutic platforms. Market Dynamics The global pseudouridine market is primarily driven by the unprecedented success and widespread adoption of mRNA vaccine technology, which has demonstrated the critical importance of pseudouridine modifications in achieving therapeutic efficacy and safety. The COVID-19 pandemic catalyzed massive investments in mRNA-based therapeutics, creating substantial demand for high-quality pseudouridine compounds and driving market expansion. Additionally, growing research activities in gene therapy, cancer immunotherapy, and RNA-based drug delivery systems are fueling market growth, as pseudouridine modifications enhance RNA stability, reduce immunogenicity, and improve therapeutic outcomes. The increasing prevalence of chronic diseases and the need for personalized medicine approaches further contribute to market drivers, as pharmaceutical companies seek innovative solutions for targeted therapies. However, the market faces significant restraints including complex manufacturing processes that require specialized expertise and sophisticated equipment, leading to high production costs and limited supplier base. Regulatory complexities surrounding RNA-based therapeutics and the stringent quality requirements for pharmaceutical-grade pseudouridine create additional barriers for market entry and expansion. Furthermore, intellectual property challenges and patent landscapes may restrict market accessibility for some manufacturers. Despite these constraints, substantial opportunities exist in emerging applications such as protein replacement therapies, tissue engineering, and regenerative medicine, where pseudouridine-modified RNAs can provide superior therapeutic benefits. The expanding pipeline of RNA-based therapeutics across various therapeutic areas, coupled with advancing manufacturing technologies and increasing research funding, presents lucrative growth prospects for market participants seeking to capitalize on the evolving landscape of molecular medicine. Key Features of the Study • This report provides in-depth analysis of the global pseudouridine market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global pseudouridine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include TriLink BioTechnologies, Yamasa Corporation Biochemicals Division, Hongene Biotech, Roche CustomBiotech, Thermo Fisher Scientific, Biosynth, Jena Bioscience, Yeasen Biotechnology, ULCHO Biochemical, Glycogene, Shanghai AECOM Biotechnology, Tianjin Scaxchem, Wuhu Huaren Science and Technology, Jinan Carbotang Biotech, and Hangzhou TCM Biotech • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global pseudouridine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pseudouridine market Market Segmentation • Product Type (chemistry) Insights (Revenue, USD Mn, 2021 - 2033) o Pseudouridine o N1-methylpseudouridine • Purity Insights (Revenue, USD Mn, 2021 - 2033) o Research Grade (RUO) o GMP / Clinical Grade o Commercial / API Grade • Form Insights (Revenue, USD Mn, 2021 - 2033) o Powder (lyophilized / crystalline) o Solution (aqueous / buffered) • Application Insights (Revenue, USD Mn, 2021 - 2033) o mRNA Therapeutics (human) o mRNA Vaccines (human) o mRNA Veterinary (vaccines / therapeutics) o Oligonucleotide / RNA Tools (controls, standards, probes) o Cell & Gene Therapy Research (RNA engineering workflows) o Diagnostics & Assays (RNA-based kits, calibration materials) • End User Insights (Revenue, USD Mn, 2021 - 2033) o Pharma & Biopharma Companies o CDMOs / CMOs (RNA synthesis, LNP formulation, fill-finish) o CROs (preclinical/clinical support labs) o Academic & Research Institutes o Government / Public Health Labs o Diagnostic Companies • Pack Size Insights (Revenue, USD Mn, 2021 - 2033) o Micro (≤100 mg) o Small (100 mg–1 g) o Medium (1–25 g) o Bulk (25 g) • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033) o Online o Offline • Regional Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o TriLink BioTechnologies o Yamasa Corporation Biochemicals Division o Hongene Biotech o Roche CustomBiotech o Thermo Fisher Scientific o Biosynth o Jena Bioscience o Yeasen Biotechnology o ULCHO Biochemical o Glycogene o Shanghai AECOM Biotechnology o Tianjin Scaxchem o Wuhu Huaren Science and Technology o Jinan Carbotang Biotech o Hangzhou TCM Biotech

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Pseudouridine Market, By Product Type (Chemistry)  Global Pseudouridine Market, By Purity  Global Pseudouridine Market, By Form  Global Pseudouridine Market, By Application  Global Pseudouridine Market, By End User  Global Pseudouridine Market, By Pack Size  Global Pseudouridine Market, By Distribution Channel  Global Pseudouridine Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trends 4. Global Pseudouridine Market, By Product Type (Chemistry), 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Pseudouridine  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o N1-methylpseudouridine  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global Pseudouridine Market, By Purity, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Research Grade (RUO)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o GMP / Clinical Grade  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Commercial / API Grade  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global Pseudouridine Market, By Form, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Powder (lyophilized / crystalline)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Solution (aqueous / buffered)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Global Pseudouridine Market, By Application, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o mRNA Therapeutics (human)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o mRNA Vaccines (human)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o mRNA Veterinary (vaccines / therapeutics)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Oligonucleotide / RNA Tools (controls, standards, probes)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Cell & Gene Therapy Research (RNA engineering workflows)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Diagnostics & Assays (RNA-based kits, calibration materials)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 8. Global Pseudouridine Market, By End User, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Pharma & Biopharma Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o CDMOs / CMOs (RNA synthesis, LNP formulation, fill-finish)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o CROs (preclinical/clinical support labs)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Academic & Research Institutes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Government / Public Health Labs  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Diagnostic Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 9. Global Pseudouridine Market, By Pack Size, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Micro (≤100 mg)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Small (100 mg–1 g)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Medium (1–25 g)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Bulk (25 g)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 10. Global Pseudouridine Market, By Distribution Channel, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Online  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Offline  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 11. Global Pseudouridine Market, By Region, 2021 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 12. Competitive Landscape o TriLink BioTechnologies  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Yamasa Corporation Biochemicals Division  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Hongene Biotech  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Roche CustomBiotech  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Thermo Fisher Scientific  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Biosynth  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Jena Bioscience  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Yeasen Biotechnology  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o ULCHO Biochemical  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Glycogene  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Shanghai AECOM Biotechnology  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Tianjin Scaxchem  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Wuhu Huaren Science and Technology  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Jinan Carbotang Biotech  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Hangzhou TCM Biotech  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 13. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 14. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on 'Pseudouridine Market' - Global forecast to 2033

提及公司

TriLink BioTechnologiesYamasa Corporation Biochemicals DivisionHongene BiotechRoche CustomBiotechThermo Fisher ScientificBiosynthJena BioscienceYeasen BiotechnologyULCHO BiochemicalGlycogeneShanghai AECOM BiotechnologyTianjin ScaxchemWuhu Huaren Science and TechnologyJinan Carbotang BiotechHangzhou TCM Biotech

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們